Platinum compounds.
Belani
C P
CP
University of Maryland Cancer Center, University of Maryland School of Medicine, Baltimore.
Van Echo
D A
DA
Aisner
J
J
D000818:Animals; D000970:Antineoplastic Agents / Q000009:adverse effects / Q000627:therapeutic use / Q000633:toxicity; D002945:Cisplatin / Q000009:adverse effects / Q000494:pharmacology* / Q000627:therapeutic use; D006801:Humans; D009944:Organoplatinum Compounds / Q000009:adverse effects / Q000494:pharmacology* / Q000627:therapeutic use / Q000633:toxicity
D000970:Antineoplastic Agents; D009944:Organoplatinum Compounds; D002945:Cisplatin